Rite Aid (RAD) Misses Q2 EPS by 2c; Trims FY16 EPS Outlook
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/24/2026
- Wall Street closes lower to end rocky week
- Meta's capital-raising plans expose a major weakness in the AI boom
- Oil prices jump $3 on Houthi attacks, oil spill, highest settlement since April
- BofA flags further downside risk for stocks, yields and dollar
- SpaceX cell-site ambitions lift tower stocks and weigh on carriers
Mizuho Securities Reiterates Buy on Rite Aid (RAD) Following 2Q16
September 17, 2015 2:29 PM EDTMizuho Securities reiterated a Buy rating and $10.00 price target on Rite-Aid (NYSE: RAD) following the company's 2Q16 earnings results. RAD reported adjusted EBITDA of $346.8mm was modestly above consensus of $344.2mm.
Analyst Ann Hynes commented, "We would be buyers of RAD on earnings-related... More
Cowen Remains Bullish on Rite Aid (RAD) Following 2c EPS Miss
September 17, 2015 1:13 PM EDTCowen reiterated an Outperform rating and $12.00 price target on Rite-Aid (NYSE: RAD) following the company's 2Q16 earnings. RAD reported EPS of $0.02, which missed consensus of $0.04. Rev of $7.66B, consisting of $6.65B from retail pharmacy and $1.07B from pharmacy services, came in ahead of... More



